AR and prostate cancer: Eyunni et al. demonstrate that n prostate cancer, the multifunctional oncogene FOXA1 has two distinct roles that are driven by different classes of mutations: one set promotes primary AR‐dependent tumorigenesis, while another confers intraluminal plasticity and induces AR‐resistant progression [200].